ストックスクリーナーアプリを入手
14.96
4.62%
0.66
アフターアワーズ：
15.10
0.14
+0.94%
前日終値:
$14.30
開ける：
$14.43
24時間の取引高:
362.39K
Relative Volume:
0.76
時価総額：
$648.61M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+19.39%
1か月 パフォーマンス:
-16.38%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$13.96
$15.06
1週間の範囲:
$12.26
$15.06
52週間の値動き範囲:
$8.89
$24.36
Beta Bionics Inc Stock (BBNX) Company Profile
BBNX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
14.96 | 543.25M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-16 | 開始されました | Truist | Buy |
| 2025-06-12 | 開始されました | Lake Street | Buy |
| 2025-05-30 | 開始されました | Goldman | Neutral |
| 2025-05-30 | 開始されました | Wolfe Research | Outperform |
| 2025-02-24 | 開始されました | BofA Securities | Buy |
| 2025-02-24 | 開始されました | Lake Street | Buy |
| 2025-02-24 | 開始されました | Leerink Partners | Outperform |
| 2025-02-24 | 開始されました | Piper Sandler | Overweight |
| 2025-02-24 | 開始されました | Stifel | Buy |
| 2025-02-20 | 開始されました | Ladenburg Thalmann | Neutral |
| 2025-02-20 | 開始されました | Robert W. Baird | Neutral |
すべてを表示
Beta Bionics Inc (BBNX) 最新ニュース
Beta Bionics Inc. Stock Analysis and ForecastFree Stock Movement Tracking - jammulinksnews.com
What drives Beta Bionics Inc. stock priceBreakthrough financial growth - jammulinksnews.com
Beta Bionics, Inc.’s Lock-Up Period Will Expire on July 29th (NASDAQ:BBNX) - Defense World
Is Beta Bionics Inc. a good long term investmentConsistent triple-digit returns - Autocar Professional
What analysts say about Beta Bionics Inc. stockOutstanding yields - Autocar Professional
Is Sprinklr Inc. a good long term investmentConsistent triple returns - jammulinksnews.com
Editas Medicine Inc. Stock Analysis and ForecastExponential wealth increase - jammulinksnews.com
NIP Group Inc. Depositary Receipt Stock Analysis and ForecastFree Investment Portfolio Suggestions - Autocar Professional
Investing in IT Sector Top Investment Strategy ToolsExplosive trading opportunities - jammulinksnews.com
SKF India Limited (SKFINDIA) Stock RalliesFree Trend-Following Techniques - jammulinksnews.com
Best Indian Stocks for Stable Returns Professional Trading PicksFree Predictions - jammulinksnews.com
Beta Bionics (BBNX) Drops 2.15% Despite Abbott Partnership - AInvest
Why Beta Bionics Inc. stock attracts strong analyst attentionFree Access to Community with 300% Return - Newser
How Beta Bionics Inc. stock performs during market volatilityFree Step-by-Step Investment Guide - Newser
What makes Beta Bionics Inc. stock price move sharplyLow Risk Scalping Alerts - Newser
Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas - MSN
Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns - Benzinga
Beta Bionics, Inc. to Release Q2 2025 Financial Results on July 29, 2025 - Nasdaq
Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewswire
Beta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Pump manufacturers: Patches are the fix for low AID uptake - BioWorld MedTech
ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors - MedTech Dive
BBNX Stock May Gain From Abbott Deal to Advance iLet Integration - Zacks Investment Research
Analysts expect Beta Bionics patch pump launch by 2027 - MassDevice
5 things to watch at the ADA’s Scientific Sessions - MedTech Dive
Beta Bionics Announces Agreement with Abbott to Integrate - GlobeNewswire
Global Artificial Pancreas Devices Market is Gearing Up for Outstanding Expansion at a CAGR of ~16% by 2032 | DelveInsight - GlobeNewswire Inc.
Beta Bionics (NASDAQ:BBNX) Now Covered by Truist Financial - Defense World
Beta Bionics initiated with a Buy at Truist - TipRanks
Beta Bionics, Inc.: Strategic Growth and Market Penetration with iLet Infusion Pump - TipRanks
Beta Bionics stock initiated with Buy rating at Truist Securities By Investing.com - Investing.com South Africa
Beta Bionics stock initiated with Buy rating at Truist Securities - Investing.com
Lake Street Capital Initiates Coverage on Beta Bionics (NASDAQ:BBNX) - Defense World
Beta Bionics, Inc. (NASDAQ:BBNX) Receives $23.13 Average Price Target from Brokerages - Defense World
Beta Bionics Executives Unload Shares in Major Stock Sell-Off! - TipRanks
Beta Bionics CEO, CFO on how to take a company public - MedTech Dive
Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges - Benzinga
Wolfe Research Initiates Coverage of Beta Bionics (BBNX) Stock with Outperform Rating - Insider Monkey
Beta Bionics (NASDAQ:BBNX) Now Covered by The Goldman Sachs Group - Defense World
Beta Bionics (NASDAQ:BBNX) Coverage Initiated by Analysts at Wolfe Research - Defense World
Goldman Sachs Initiates Coverage of Beta Bionics (BBNX) with Neutral Recommendation - Nasdaq
Goldman Sachs sets Beta Bionics stock at Neutral with $16 target - Investing.com Australia
Beta Bionics Inc (BBNX) 財務データ
Beta Bionics Inc (BBNX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.64%
0.34%
大文字化:
|
ボリューム (24 時間):